Sort
10,766 grants matching “checkpoint inhibitor”
Project 2: Adoptive Cell Therapies for Chordomas
$319,676Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2025 · CA
Expression of Class I Specific Receptors in NK Cells
$319,652David H Raulet · University Of California Berkeley · R01 · FY2009 · AI
Therapeutic targeting of stratifin structure and function
$319,550Jian-Ting Zhang · Indiana University Indianapolis · R01 · FY2010 · CA
The SIK2 Inhibitor GRN-300 Enhances PARP Inhibitor Sensitivity and Cytotoxic T-Cell Function in Ovarian Cancer
$319,498Robert C Bast · University Of Tx Md Anderson Can Ctr · P50 · FY2024 · CA
Targeting EGFL6 in Ovarian Cancer
$319,497Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2024 · CA
53BP1-Mediated Regulation of DNA Repair and Chemoresistance
$319,383Shridar Ganesan · Rbhs -Cancer Institute Of New Jersey · R01 · FY2014 · CA
Roles of Lig3 and XRCC1 Genes in Genome Stability
$319,311Alan E Tomkinson · University Of New Mexico Health Scis Ctr · R01 · FY2016 · ES
Roles of Checkpoint and DNA Repair Proteins in Fission Yeast Telomere Maintenance
$319,296Toru Nakamura · University Of Illinois At Chicago · R01 · FY2011 · GM
Role of RecQ Helicases to Prevent Senescence By c-Myc
$319,185Denise A. Galloway · Fred Hutchinson Cancer Research Center · R01 · FY2006 · AG
Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer
$319,163Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R34 · FY2024 · CA
Molecular Targeted Radionuclide Therapy with Tumor-Specific Vaccine to Stimulate and Expand T-cell Activation
$319,122Douglas G McNeel · University Of Wisconsin-Madison · P01 · FY2022 · CA
Molecular Targeted Radionuclide Therapy with Tumor-Specific Vaccine to Stimulate and Expand T-cell Activation
$319,121Douglas G McNeel · University Of Wisconsin-Madison · P01 · FY2023 · CA
Project 3: The Functional Contribution of Tumor Immunity in PDAC
$319,026Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
Translational Events in Platelets
$318,945Andrew Scott Weyrich · University Of Utah · R01 · FY2007 · HL
Translational Events in Platelets
$318,945Andrew Scott Weyrich · University Of Utah · R01 · FY2008 · HL
The Role of AKT in Prostate Cancer
$318,864William R Sellers · Beth Israel Deaconess Medical Center · P01 · FY2008 · CA
Project 1: Hypoxia and metabolic dysregulation as a targetable barrier to immunotherapy in head and neck squamous cell carcinoma (HNSCC)
$318,776Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA
Project 4
$318,724Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2025 · CA
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
$318,600Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
A Novel Pathway Involving E2F1, ATM and NBS1
$318,565David G. Johnson · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
Jun Kinase Signaling and Apoptosis in Ischemia Stroke
$318,488Children'S Hospital Med Ctr (Cincinnati) · R01 · FY2004 · NS
Jun Kinase Signaling and Apoptosis in Ischemia Stroke
$318,488Children'S Hospital Med Ctr (Cincinnati) · R01 · FY2003 · NS
Mechanism(s) of Hepatocyte Transformation by the Hepatitis B Virus X Protein
$318,390Ourania M. Andrisani · Purdue University · R01 · FY2014 · DK
Project-002
$318,307Gurjit K Khurana Hershey · Cincinnati Childrens Hosp Med Ctr · U19 · FY2020 · AI
Effect of anti-S phase agents on human chromosomes
$318,015Anindya Dutta · University Of Virginia · R01 · FY2014 · CA